Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Bullock

Showing results (201-210 of 220) with videos related to

Pageof 22
Sort By:
Science Signaling|May 24, 2018
The DUF1669 domain of FAM83 family proteins anchor casein kinase 1 isoformsLuke J Fulcher, Polyxeni Bozatzi, Theresa Tachie-Menson, et al.
JCI Insight|June 15, 2017
Mitochondrial dysregulation and glycolytic insufficiency functionally impair CD8 T cells infiltrating human renal cell carcinomaPeter J Siska, Kathryn E Beckermann, Frank M Mason, et al.
Elife|July 25, 2023
Discovery and characterization of a specific inhibitor of serine-threonine kinase cyclin-dependent kinase-like 5 (CDKL5) demonstrates role in hippocampal CA1 physiologyAnna Castano, Margaux Silvestre, Carrow I Wells, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 30, 2013
Structures of ABCB10, a human ATP-binding cassette transporter in apo- and nucleotide-bound statesChitra A Shintre, Ashley C W Pike, Qiuhong Li, et al.
Biorxiv : the Preprint Server for Biology|April 17, 2026
Overlapping MHC class I/II Epitopes Program cDC1-like Differentiation of Monocyte-Derived Dendritic Cells via mTORC1 Signaling InhibitionS B Amanya, A Murthy, N Bisht, et al.
Communications Biology|May 18, 2019
ALK2 inhibitors display beneficial effects in preclinical models of <i>ACVR1</i> mutant diffuse intrinsic pontine gliomaDiana Carvalho, Kathryn R Taylor, Nagore Gene Olaciregui, et al.
Journal of Medicinal Chemistry|November 21, 2024
Covalent Inhibitors of KEAP1 with Exquisite SelectivityImre Fejes, Piroska Markacz, Janos Tatai, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|September 9, 2015
Mutations in Known Monogenic High Bone Mass Loci Only Explain a Small Proportion of High Bone Mass CasesCelia L Gregson, Lawrie Wheeler, Sarah A Hardcastle, et al.
Angewandte Chemie (International Ed. in English)|August 21, 2025
Fragment-Based Drug Discovery of Novel High-affinity, Selective, and Anti-inflammatory Inhibitors of the Keap1-Nrf2 Protein-Protein InteractionChunyu Lin, Dilip Narayanan, Marilia Barreca, et al.
Journal of Medicinal Chemistry|August 14, 2020
Leveraging an Open Science Drug Discovery Model to Develop CNS-Penetrant ALK2 Inhibitors for the Treatment of Diffuse Intrinsic Pontine GliomaDavid Smil, Jong Fu Wong, Eleanor P Williams, et al.
Pageof 22

Showing results (201-210 of 220) with videos related to

Sort By:
Pageof 22
Science Signaling|May 24, 2018
The DUF1669 domain of FAM83 family proteins anchor casein kinase 1 isoformsLuke J Fulcher, Polyxeni Bozatzi, Theresa Tachie-Menson, et al.
JCI Insight|June 15, 2017
Mitochondrial dysregulation and glycolytic insufficiency functionally impair CD8 T cells infiltrating human renal cell carcinomaPeter J Siska, Kathryn E Beckermann, Frank M Mason, et al.
Elife|July 25, 2023
Discovery and characterization of a specific inhibitor of serine-threonine kinase cyclin-dependent kinase-like 5 (CDKL5) demonstrates role in hippocampal CA1 physiologyAnna Castano, Margaux Silvestre, Carrow I Wells, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 30, 2013
Structures of ABCB10, a human ATP-binding cassette transporter in apo- and nucleotide-bound statesChitra A Shintre, Ashley C W Pike, Qiuhong Li, et al.
Biorxiv : the Preprint Server for Biology|April 17, 2026
Overlapping MHC class I/II Epitopes Program cDC1-like Differentiation of Monocyte-Derived Dendritic Cells via mTORC1 Signaling InhibitionS B Amanya, A Murthy, N Bisht, et al.
Communications Biology|May 18, 2019
ALK2 inhibitors display beneficial effects in preclinical models of <i>ACVR1</i> mutant diffuse intrinsic pontine gliomaDiana Carvalho, Kathryn R Taylor, Nagore Gene Olaciregui, et al.
Journal of Medicinal Chemistry|November 21, 2024
Covalent Inhibitors of KEAP1 with Exquisite SelectivityImre Fejes, Piroska Markacz, Janos Tatai, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|September 9, 2015
Mutations in Known Monogenic High Bone Mass Loci Only Explain a Small Proportion of High Bone Mass CasesCelia L Gregson, Lawrie Wheeler, Sarah A Hardcastle, et al.
Angewandte Chemie (International Ed. in English)|August 21, 2025
Fragment-Based Drug Discovery of Novel High-affinity, Selective, and Anti-inflammatory Inhibitors of the Keap1-Nrf2 Protein-Protein InteractionChunyu Lin, Dilip Narayanan, Marilia Barreca, et al.
Journal of Medicinal Chemistry|August 14, 2020
Leveraging an Open Science Drug Discovery Model to Develop CNS-Penetrant ALK2 Inhibitors for the Treatment of Diffuse Intrinsic Pontine GliomaDavid Smil, Jong Fu Wong, Eleanor P Williams, et al.
Pageof 22